Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
News, developments and strategies related to eClinical, data management, data collection, ePRO, and more information technology used in the drug development chain. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
In less than two weeks, I’ll be in Philadelphia for CBI’s ClinTech 2013 event at the Loew’s Hotel. For the first day of the event, morning keynotes, an FDA address, and a TechVision panel, moderated by me, precede lunch and an afternoon breakout by operational interest. Four eClinical tracks are broken out on the second day of the event-- CTMS, eTMF, portals and EDC. If you have a moment, take this survey on CTMS which will support that track.
Coincidentally, I’ve been reading over our own eClinical: Directions for 2013 insert that is debuting online soon, covering many trends: technology integration, mobile technology, single sign-on, and more as a need to leverage all the data that is collected in clinical trials. Between this and preparing for the conference, I am immersed in eClinical. Which is good because there are many indications that eClinical and tech adoption is making progress after a couple of quiet years during the economic strain in the industry.
The TechVision panel is already proving interesting based on the expert areas of interest and experience of the members. Those members are: Robin DeMent, Vice President, R&D-IT Medical Development Capabilities for GlaxoSmithKline; Dharma Bhagavathi, Head of Clinical Technology Office, Sanofi Clinical Sciences & Operations
; Kevin Johnson, Business Infrastructures Department,
Teva Pharmaceutical Industries Ltd; and Henry Levy, Managing Director, Accenture Life Sciences Research and Development.
Whether or not we discuss those topics at the panel remains to be seen because it will be an audience-driven event. Based on my previous experience at CBI conferences, I expect that audience participation will be high and so will the interaction.
eClinical technology, choices of software and delivery mode, integration, etc., is on-going, so Applied Clinical Trials and CBI will continue to deliver information on these topics all year. Technology truly is the backbone of this industry and you can’t talk about one topic without bringing the supporting technology into it. Look for our eClinical insert online in March and take a peak at CBI’s 10th Forum on Patient Reported Outcomes agenda for May 6 & 7, also in Philadelphia.